Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study

Journal of Gynecologic Oncology ◽

10.3802/jgo.2021.32.e24 ◽

2021 ◽

Vol 32 (2) ◽

Keyword(s):

Cancer Treatment ◽

Hospital Volume ◽

Vulvar Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Outcome Relationship ◽

Download Full-text

Volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/s0090-8258(21)00744-7 ◽

2021 ◽

Vol 162 ◽

pp. S53

Author(s):

Shin Nishio ◽

Koji Matsuo ◽

Shinya Matsuzaki ◽

Hiroko Machida ◽

Mikio Mikami ◽

...

Keyword(s):

Cancer Treatment ◽

Vulvar Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Outcome Relationship ◽

Download Full-text

Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.12.028 ◽

2009 ◽

Vol 113 (1) ◽

pp. 52-56 ◽

Author(s):

Frederick B. Stehman ◽

Shamshad Ali ◽

Philip J. DiSaia

Keyword(s):

Vulvar Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Download Full-text

Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(09)79091-5 ◽

2009 ◽

Vol 2009 ◽

pp. 258

Author(s):

L.P. Shulman

Keyword(s):

Vulvar Cancer ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Download Full-text

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70331-2 ◽

2007 ◽

Vol 2007 ◽

pp. 82-83

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Whole Abdominal Radiotherapy in the Adjuvant Treatment of Patients With Stage III and IV Endometrial Cancer: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70597-6 ◽

2006 ◽

Vol 2006 ◽

pp. 449-452

Author(s):

S.D. Yamada

Keyword(s):

Endometrial Cancer ◽

Adjuvant Treatment ◽

Gynecologic Oncology ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Abdominal Radiotherapy

Download Full-text

Faculty Opinions recommendation of Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969752.793471344 ◽

2013 ◽

Author(s):

David Kushner ◽

Ryan Spencer

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Faculty Opinions recommendation of A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.722006345.793527263 ◽

2017 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Cancer ◽

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Download Full-text

Faculty Opinions recommendation of Randomized phase II evaluation of bevacizumab versus bevacizumab plus fosbretabulin in recurrent ovarian, tubal, or peritoneal carcinoma: an NRG oncology/gynecologic oncology group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726377012.793527326 ◽

2017 ◽

Author(s):

Katherine Fuh

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8972962.9534062 ◽

2011 ◽

Author(s):

Lee-May Chen

Keyword(s):

Gynecologic Oncology ◽

Low Risk ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)

American Journal of Obstetrics and Gynecology ◽

10.1016/0002-9378(89)90507-3 ◽

1989 ◽

Vol 161 (2) ◽

pp. 309-312 ◽

Author(s):

Gregory P. Sutton ◽

John A. Blessing ◽

Neil Rosenshein ◽

Guy Photopulos ◽

Philip J. DiSaia

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text